Lynparza 150mg Tablets

Usage/Application tumor
Composition olaparib
Drug Name olaparib
Packaging Type tab
Dose/Strength 150mg
Dosage Form 150mg
Brand lynparza
Form of Medicine tablets
Storage Condition room teprature
No of tablets 56



Generic Content-Olaparib , Manufactured By:Astrazeneca

Olaparib is an FDA-approved targeted therapy for cancer. It is a PARP inhibitor, inhibiting poly ADP ribose polymerase, an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which include some ovarian, breast, and prostate cancers.

Olaparib is indicated as monotherapy for the treatment of metastatic or locally advanced cancer in patients whose tumors are resistant.


There are no reviews yet.

Be the first to review “Lynparza 150mg Tablets”

Your email address will not be published. Required fields are marked *

Select the fields to be shown. Others will be hidden. Drag and drop to rearrange the order.
  • Image
  • SKU
  • Rating
  • Price
  • Stock
  • Availability
  • Add to cart
  • Description
  • Content
  • Weight
  • Dimensions
  • Additional information
  • Attributes
  • Custom attributes
  • Custom fields
Click outside to hide the compare bar
Wishlist 0
Open wishlist page Continue shopping